| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |